Biomarkers Predict In-Hospital Major Adverse Cardiac Events in COVID-19 Patients: A Multicenter International Study
Michael Y. Henein,Giulia Elena Mandoli,Maria Concetta Pastore,Nicolò Ghionzoli,Fouhad Hasson,Muhammad K. Nisar,Mohammed Islam,Francesco Bandera,Massimiliano M. Marrocco-Trischitta,Irene Baroni,Alessandro Malagoli,Luca Rossi,Andrea Biagi,Rodolfo Citro,Michele Ciccarelli,Angelo Silverio,Giulia Biagioni,Joseph A. Moutiris,Federico Vancheri,Giovanni Mazzola,Giulio Geraci,Liza Thomas,Mikhail Altman,John Pernow,Mona Ahmed,Ciro Santoro,Roberta Esposito,Guillem Casas,Rubén Fernández-Galera,Maribel Gonzalez,Jose Rodriguez Palomares,Ibadete Bytyçi,Frank Lloyd Dini,Paolo Cameli,Federico Franchi,Gani Bajraktari,Luigi Paolo Badano,Matteo Cameli
DOI: https://doi.org/10.3390/jcm10245863
IF: 3.9
2021-12-14
Journal of Clinical Medicine
Abstract:Background: The COVID-19 pandemic carries a high burden of morbidity and mortality worldwide. We aimed to identify possible predictors of in-hospital major cardiovascular (CV) events in COVID-19. Methods: We retrospectively included patients hospitalized for COVID-19 from 10 centers. Clinical, biochemical, electrocardiographic, and imaging data at admission and medications were collected. Primary endpoint was a composite of in-hospital CV death, acute heart failure (AHF), acute myocarditis, arrhythmias, acute coronary syndromes (ACS), cardiocirculatory arrest, and pulmonary embolism (PE). Results: Of the 748 patients included, 141(19%) reached the set endpoint: 49 (7%) CV death, 15 (2%) acute myocarditis, 32 (4%) sustained-supraventricular or ventricular arrhythmias, 14 (2%) cardiocirculatory arrest, 8 (1%) ACS, 41 (5%) AHF, and 39 (5%) PE. Patients with CV events had higher age, body temperature, creatinine, high-sensitivity troponin, white blood cells, and platelet counts at admission and were more likely to have systemic hypertension, renal failure (creatinine ≥ 1.25 mg/dL), chronic obstructive pulmonary disease, atrial fibrillation, and cardiomyopathy. On univariate and multivariate analysis, troponin and renal failure were associated with the composite endpoint. Kaplan–Meier analysis showed a clear divergence of in-hospital composite event-free survival stratified according to median troponin value and the presence of renal failure (Log rank p < 0.001). Conclusions: Our findings, derived from a multicenter data collection study, suggest the routine use of biomarkers, such as cardiac troponin and serum creatinine, for in-hospital prediction of CV events in patients with COVID-19.
medicine, general & internal